Close X
Get more out of
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.

Click here if you're interested
Helping you make better health choices

What Doctors Don't Tell You

In shops now or delivered to your home from only £3.50 an issue!

July 2020 (Vol. 5 Issue 5)

Don’t treat slow-growing prostate cancer, say researchers
About the author: 
Bryan Hubbard

Don’t treat slow-growing prostate cancer, say researchers image

Men who’ve recently been diagnosed with slow-growing prostate cancer can safely adopt a ‘watchful waiting’ strategy instead of having it immediately treated, a new study has found.

The vast majority of Swedish men who have low-risk cancer are choosing active surveillance, which involves regular check-ups and blood tests—and they are likely to live just as long as those who opt for treatment, such as radiotherapy or surgery.

Up to 91 per cent of men in Sweden diagnosed with very low-risk prostate cancer, and 74 per cent with low-risk cancer, are choosing active surveillance over treatment, say researchers from New York University’s Langone Medical Center.

The researchers had analysed the response to the cancer diagnosis of 32,518 Swedish men over five years.

The response in the US to a prostate cancer diagnosis is invariably aggressive, with immediate treatment recommended, but the ‘take home’ message for Americans is that they, too, could benefit from a ‘watchful waiting’ approach, say the researchers.

Other studies have found that the life expectancy of those who opt for treatment and those who don’t is around the same, although those who have their cancer treated are likely to suffer from some life-destroying side effect, such as incontinence or impotence, said lead researcher Stacy Loeb.


(Source: JAMA Oncology, 2016; doi: 10.1001.jamaoncol.2016.3600)

You may also be interested in...

Support WDDTY

Help support us to hold the drugs companies, governments and the medical establishment accountable for what they do.


Latest Tweet


Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions..

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

© 2010 - 2020 WDDTY Publishing Ltd.
All Rights Reserved